Soft Tissue Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas
Conditions: Locally Advanced Soft Tissue Sarcoma Interventions: Drug: Lurbinectedin; Radiation: Radiotherapy; Procedure: Non-investigational surgery Sponsors: University of California, San Francisco; Jazz Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety
Conditions: Sarcoma; Soft Tissue Sarcoma Sponsors: Centre Hospitalier Universitaire de Besancon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Second Line Treatment.
Conditions: Sarcoma Metastatic; Locally Advanced Soft Tissue Sarcoma Interventions: Other: Dematerialized Personalized Care Plan (ePCP) Sponsors: Centre Oscar Lambret; Cancerop ôle Nord Ouest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Conditions: Refractory Bone and Soft Tissue Sarcomas Interventions: Drug: Fruquintinib Sponsors: Peking University People ' s Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Conditions: Osteosarcoma; Sarcoma; Soft Tissue Sarcoma; Bone Tumor Interventions: Drug: Recombinant oncolytic herpes simplex virus type Ⅰ (R130) Sponsors: Shanghai Yunying Medical Technology; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
Conditions: Neoadjuvant; Immunotherapy; Sarcoma,Soft Tissue; Radiation Therapy Interventions: Drug: Pembrolizumab, Eftilagimod alpha Sponsors: Maria Sklodowska-Curie National Research Institute of Oncology; Immutep S.A.S. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Conditions: Sarcoma; Bone Sarcoma; Soft Tissue Sarcoma Interventions: Other: referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences. Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials

Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Conditions: Sarcoma Interventions: Drug: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell) Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Conditions: Osteosarcoma; Soft Tissue Sarcoma Interventions: Drug: NK510; Drug: NK510 Sponsors: Base Therapeutics (Shanghai) Co., Ltd.; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Conditions: Sarcoma, Soft Tissue Interventions: Drug: Cardunilizumab Sponsors: Xiangya Hospital of Central South University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)
Conditions: Sarcoma,Soft Tissue Interventions: Drug: Selinexor 20 MG; Drug: Gemcitabine Sponsors: Asociaci ón Europea y Latinoamericana SELNET para la Investigación en Sarcomas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma Adult Interventions: Drug: Surufatinib Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials

5-Day Preoperative Radiation for Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma Interventions: Radiation: External Beam Radiotherapy Sponsors: Stanford University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Conditions: Adult Soft Tissue Sarcoma; Non Small Cell Lung Cancer; Triple Negative Breast Cancer; Colorectal Cancer; Biliary Tract Cancer Interventions: Drug: Ezabenlimab + BI907828 Sponsors: Institut Bergoni é; Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA): a Prospective Phase 2 Trial
Conditions: Sarcoma; Sarcoma,Soft Tissue; Sarcoma of Bone Interventions: Combination Product: Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT) Sponsors: Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials